Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: A case report

Journal of Clinical Psychopharmacology

Volumn 32, Issue 5, 2012, Pages 723-724

  Albayrak, Yakup ^a   Ekinci, Okan ^b  

^a KNrklareli State Hospital   (Turkey)

^b Yozgat State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; FLUVOXAMINE;

ADULT; BRAIN RADIOGRAPHY; CASE REPORT; DECREASED APPETITE; DEPRESSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DSM-IV; FATIGUE; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; INSOMNIA; LETTER; MAJOR DEPRESSION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT CARE; PRIORITY JOURNAL; TARDIVE DYSKINESIA;

DEPRESSIVE DISORDER; DYSKINESIA, DRUG-INDUCED; FEMALE; FLUVOXAMINE; HUMANS; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; TREATMENT OUTCOME;

EID: 84865864743     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182686619     Document Type: Letter

References (18)

1. Jeste DV, Rockwell E, Harris MJ, et al. Conventional vs. newer antipsychotics in elderly patients. Am J Geriatr Psychiatry. 1999;7:70-76.
2. Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol. 1995;18(3):197-214.
3. Lavalaye J, Sarlet A, Booij J, et al. Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study. Psychopharmacology (Berl). 2001; 155:107-109.
4. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry. 1996;57:449-454.
5. Yassa R, Camille Y, Belzile L. Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and review of the literature. J Clin Psychopharmacol. 1987;7(4):243-246.
6. Dubovsky SL, Thomas M. Tardive dyskinesia associated with fluoxetine. Psychiatr Serv. 1996;47(9):991-993.
7. Boffa E, Lofchy J. Paroxetine and tardive akathisia. Can J Psychiatry. 2000;45(4):398.
8. Lee Y, Yeh WC, Chong MY, et al. Venlafaxine and tardive blepharospasm: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(5):1139-1140.
9. Birthi P,Walters C, Karandikar N. A rare case of tardive dyskinesia and akathisia induced by citalopram. PM R. 2010;2(10):973-975.
10. Lin CC, Lin PY, Lee Y, et al. Tardive dystonia and tardive sensory syndrome related to trazodone: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(6):1609-1610.
11. Chen PY, Lin PY, Tien SC, et al. Duloxetine-related tardive dystonia and tardive dyskinesia: a case report. Gen Hosp Psychiatry. 2010;32(6):646-649.
12. Deuschle M, Mase E, Zink M. Dyskinesia during treatment with duloxetine. Pharmacopsychiatry. 2006;39(6):237-238.
13. Kenney C, Hunter C, Davidson A, et al. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol. 2008;48(3):379-384.
14. Ishikawa M, Ishikawa M, Ishii K, et al. High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. Biol Psychiatry. 2007; 62(8):878-883.
15. Alonso G, Phan V, Guillemain I, et al. Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience. 2000;97(1):155-170.
16. Furuse T, Hashimoto K. Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases. Ann Gen Psychiatry. 2010;24;9-17.
17. Furuse T, Hashimoto K. Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors. Ann Gen Psychiatry. 2010;6:9-11.
18. Çayköylü A, Albayrak Y, Uurlu GK, et al. Beneficial effects of fluvoxamine for hemiballism in a patient with depressive disorder: a case report. Acta Neurol Belg. 2011;111:62-65.